[In vitro and in vivo activities of norfloxacin, ofloxacin and ciprofloxacin against various mycobacteria].
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use; D002939:Ciprofloxacin / Q000494:pharmacology* / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D005260:Female; D051379:Mice; D009161:Mycobacterium / Q000187:drug effects*; D009164:Mycobacterium Infections / Q000188:drug therapy*; D009165:Mycobacterium Infections, Nontuberculous / Q000188:drug therapy*; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D009170:Nontuberculous Mycobacteria / Q000187:drug effects*; D009643:Norfloxacin / Q000494:pharmacology* / Q000627:therapeutic use; D015242:Ofloxacin; D010078:Oxazines / Q000494:pharmacology* / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D010078:Oxazines; D002939:Ciprofloxacin; D015242:Ofloxacin; D009643:Norfloxacin